RxDoctor Payments Data

Jeremy Webb, MD

Family Medicine · Eddyville, KYNPI 1609307255

Payments from drug & device makers

$4,031in general payments, 2019–2025

Across 290 payments — averaging $13.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$480
  • Otsuka America Pharmaceutical, Inc.$470
  • Corium, LLC$325
  • Boehringer Ingelheim$254
  • Amgen$222
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$4,031100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,031 in reported general payments places this provider in the 80th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$61,817
Medicare patients
96
Services billed
824

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban38$25,255
OzempicSemaglutide22$23,751
MounjaroTirzepatide19$19,875
FarxigaDapagliflozin Propanediol14$10,542
JardianceEmpagliflozin13$9,674
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,168
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,169
VyvanseLisdexamfetamine Dimesylate11$4,356
Gabapentin79$764
Pantoprazole Sodium45$601
Albuterol Sulfate HfaAlbuterol Sulfate14$478
Eszopiclone13$470
Atorvastatin Calcium82$416
Testosterone Cypionate14$378
Oxybutynin Chloride ErOxybutynin Chloride11$371

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$149$25,25538 claims
Novo NordiskOzempic$480$23,75122 claims
Lilly USA, LLCMounjaro$161$19,87519 claims
AstraZenecaFarxiga, Breztri Aerosphere$78$18,71027 claims
Boehringer IngelheimJardiance, Stiolto Respimat$254$14,84224 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$13$4,35611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Eddyville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →